All In MedTech

Device Trial Radar · NCT04186546

Zephyr Valve Registry (ZEVR)

Zephyr Valve Registry

Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Nov 25, 2019

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Pulmonx CorporationPublic (LUNG)
Sponsor type
Industry
First posted
Dec 4, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Post-Approval Registry is to gather ongoing safety and effectiveness assessment of the Zephyr Valve treatment in a real-world setting.

Conditions

  • Emphysema

Interventions

  • Zephyr Valve ProcedureDevice

    The Pulmonx Zephyr Endobronchial Valve is an implantable bronchial valve intended to decrease volume in targeted regions of the lung. It is indicated for the treatment of patients with severe emphysema. The Zephyr Valves are placed in the diseased region of the lung using bronchoscopy. As the diseased region of the lung shrinks in size, healthier regions may expand and function more efficiently, resulting in improved breathing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence Rate of Pneumothorax from Baseline to 45-days post-procedureTime frame: Baseline to 45-days post-procedure
  2. Incidence Rate of Serious Adverse Events (SAEs) of Interest from Baseline to 3 years post-procedureTime frame: Baseline to 3 years post-procedure

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • University of Chicago

    Chicago, Illinois

  • Northwestern Medicine

    Winfield, Illinois

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.